Interstitial fibrosis increases the risk of end-stage kidney disease in patients with lupus nephritis.

MLA

Sun, Yi-Syuan, et al. “Interstitial Fibrosis Increases the Risk of End-Stage Kidney Disease in Patients with Lupus Nephritis.” Rheumatology, vol. 63, no. 9, Sept. 2024, pp. 2467–72. EBSCOhost, https://doi.org/10.1093/rheumatology/keae226.

APA

Sun, Y.-S., Huang, D.-F., Chang, F.-P., Chen, W.-S., Liao, H.-T., Chen, M.-H., Tsai, H.-C., Tsai, M.-T., Tsai, C.-Y., Lai, C.-C., & Yang, C.-Y. (2024). Interstitial fibrosis increases the risk of end-stage kidney disease in patients with lupus nephritis. Rheumatology, 63(9), 2467–2472. https://doi.org/10.1093/rheumatology/keae226

Chicago

Sun, Yi-Syuan, De-Feng Huang, Fu-Pang Chang, Wei-Sheng Chen, Hsien-Tzung Liao, Ming-Han Chen, Hung-Cheng Tsai, et al. 2024. “Interstitial Fibrosis Increases the Risk of End-Stage Kidney Disease in Patients with Lupus Nephritis.” Rheumatology 63 (9): 2467–72. doi:10.1093/rheumatology/keae226.